Attendees at this year’s Southern Council of Optometrists (SECO) meeting were greeted with a surprise: a quick game of $1 or Mystery Box!
The gifts weren’t free, though — recipients had to face the challenge of answering a question about presbyopia drops!
Test Your Knowledge on Presbyopia Myths
Do you know why the following are important to know before prescribing presbyopia drops?
How do you differentiate between all the different types of presbyopia drops available?
A Pharmaceutical Approach To Presbyopia Treatment
The pharmacological approach to treatment provides a local, non-invasive, and reversible treatment for presbyopia. Generally, these eye drops cause miosis and enhance depth of focus through a pinhole effect. Before prescribing the miotic pilocarpine, it is essential to assess the risk of retinal detachment.1
Proper patient selection is crucial. The refractive profiles that typically respond best include emmetropes, mild myopes, low hyperopes, pseudophakic patients, and those who have undergone post-refractive surgery.
Not all drops are created equal. QLOSI (pilocarpine ophthalmic solution, 0.4%) is the lowest FDA-approved pilocarpine concentration.2 It is also the only eye drop with a single-digit rate of ocular adverse events3 while having minimal ciliary muscle effect.3
